Aims To examine all-cause and cause-specific mortality in a population-based cohort of people with early and late onset of Type 1 diabetes.
Introduction
Population-based registers have shown excess mortality for individuals with Type 1 diabetes compared with the general population [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Reduced mortality in recent years for children diagnosed with Type 1 diabetes suggests decreasing excess mortality [1,2,9,11], but few studies have examined this trend in Type 1 diabetes onset among adolescents and young adults. In a Finnish cohort, Harjutsalo et al. [3] analysed mortality in early (diagnosis at age <15 years) and late onset (diagnosis at age 15-29 years). They found lower mortality over time with early-onset, whilst mortality from acute complications increased with late-onset Type 1 diabetes. In the UK, data from the Yorkshire Register of Type 1 diabetes in Children and Young People (YRDCYP) showed no difference in standardized mortality ratios (SMRs) between those with early-and those with late-onset Type 1 diabetes [7] ; however, no comparisons were made between onset groups over time, and there was no examination according to ethnicity and deprivation status, which are often under-examined demographic factors in UK mortality studies.
Cause-specific mortality from the YRDCYP found a third and a fifth of deaths were attributable to acute and chronic complications of Type 1 diabetes, respectively [7] ; however, these results were based on death certification data without clinical validation, which may have led to inaccuracies, particularly for diabetes-related deaths. Other studies have
Correspondence to: Richard G. Feltbower. E-mail: R.G.Feltbower@leeds.ac.uk noted the frequent omission of Type 1 diabetes from death certificates. For example, Laing et al. [12] showed that only 67% of death certificates for a cohort with Type 1 diabetes mentioned diabetes. These diabetes-related deaths were reassessed for reclassification with regard to cardiovascular or renal disease, but no reassessment was made with regard to non-diabetes-related deaths.
The YRDCYP now includes data up to 2013, with linked death certification data up to the end of 2015. The aim of the present study was to examine associations between demographic factors (Type 1 diabetes onset age, sex, ethnicity and deprivation status) and all-cause and causespecific mortality risk. Mortality risk over time was also analysed to test the hypothesis that mortality risk would decrease with time.
Research design and methods

Study cohort
The YRDCYP includes data on all children aged <15 years (early-onset group) diagnosed with diabetes between 1978 and 2013 in the Yorkshire Regional Health Authority (YRHA). The YRHA has an estimated population of 5.3 million (9% of the population of England and Wales) [13] . The estimated prevalence of Type 1 diabetes in the YRHA is 0.81%, twice that in England as a whole (0.4%) [14] .
The YRDCYP also includes data on 15-29 year olds (lateonset group) diagnosed between 1991 to 2013 in West Yorkshire (Bradford, Calderdale, Kirklees, Leeds and Wakefield). West Yorkshire includes 57% of the total YRHA population [15] .
Individuals diagnosed with Type 1 diabetes recorded at the latest diagnosis date were included in the cohort. Individuals diagnosed with Type 1 diabetes as a secondary condition were excluded.
In England and Wales, diabetes care is available for people aged up to 24 years at specialist Paediatric Diabetes Units, although transfer to adult services can occur from 16 years. The YRDCYP collects data from all specialist diabetes services and from primary care for data validation. Further details on data collection are described in Feltbower et al. [6] .
Demographic data
Information on ethnicity was unavailable because of inconsistent data recording. We therefore used Onomap software to categorize ethnicity using the individual's full name to calculate probability scores according to religion, geographic origin, ethnic background and language. Despite sensitivity issues for classifying non-British identities, Onomap was the preferred ethnicity algorithm because of its extensive coverage of ethnicities and number of identity dimensions used to derive a classification [16] . Individuals with incomplete names or names of ambiguous origin were classified as 'unknown ethnicity'.
The Townsend index was used to categorize individuals into deprivation groups, using a material deprivation definition from the UK decennial census variables (unemployment, overcrowded households, car/van ownership, home ownership) [17] . The census year 2001 was chosen as this lay approximately midway within the cohort period. A Townsend index score was assigned to each YRHA 2001 UK census ward area and ordered and divided into five groups from 'Most deprived fifth' to 'Least deprived fifth'. For individuals with early-onset Type 1 diabetes, deprivation group was assigned according to geocoding YRHA ward area by place of residence at diagnosis. West Yorkshire includes the most deprived and populated wards within the YRHA, so geocoding ward area for late-onset Type 1 diabetes using the YRHA would inflate the most deprived groups; therefore, the late-onset group used geocoding from West Yorkshire ward areas only.
Linking the YRDCYP with Office for National Statistics mortality data
The YRDCYP was linked to Office for National Statistics death certification data up to 31 December 2015 using National Health Service (NHS) number (this identifies a person's health record in England and Wales), date of birth, gender and name. Consent for data linkage was obtained through the ethics approval granted for this study. Data included date of death, free text from death certificates and the derived International Classification of Diseases, 10th revision (ICD-10) codes for underlying cause of death. The ICD-10 code was clinically verified (by H.J.B.) against the free text. Underlying cause of death was defined as 'the disease or injury which initiated the What's new?
• Population-based registers have shown decreasing mortality in early-onset (age <15 years) Type 1 diabetes, but analysis of mortality in late-onset (age 15-29 years) is lacking.
• The Yorkshire Register of Diabetes in Children and Young People is the largest sub-national populationbased dataset in the UK (5498 individuals with 100 959 person-years of follow-up). We found that all-cause mortality had fallen over time, but there was no improvement in mortality rates for deaths attributable to acute complications for either onset group.
• We highlight the importance of clinical verification of death certification data for accurate reporting of causespecific mortality.
train of morbid events leading directly to death, or the circumstances of the accident or violence which produced the fatal injury' [18] ; therefore, deaths coded as nondiabetes-related (e.g. attributed to cardiovascular or renal disease) but which were initiated by diabetes were reclassified under diabetes. Underlying cause of death categories included diabetes (E10-E14), respiratory failure (J00-J98), ischaemic heart disease (I20-I25), neoplasms (C00-C97, D00-D48), mental disorder (F00-F99), accidents and violence (S00-T98, V00-X59, X85-Y98), suicide (X60-X84) and other/unknown causes. Deaths attributable to acute complications were classified as diabetes-related deaths with coma or ketoacidosis. All other diabetesrelated deaths with other complications were classified under chronic complications.
Statistical analysis
Standardized mortality ratios
All analyses were performed using STATA 14. SMRs with 95% CIs, assuming a Poisson distribution, compared mortality in the study cohort with that of the general population. Population and death data for the YRHA were unavailable; therefore, population and death totals in England and Wales from 1978 to 2014, stratified by 5-year age bands and sex, were used to calculate mortality rates in the general population. Although the population of England and Wales and mortality rates include individuals with Type 1 diabetes, because of the low prevalence of Type 1 diabetes (0.4% [19] ), any bias in SMRs is likely to remain low [20] . SMRs for diabetes-related deaths were not calculated, as national Type 1 diabetes population figures were unavailable.
Survival analysis
Cumulative mortality plots using Kaplan-Meier survival estimates were produced against time since diabetes diagnosis by sex, ethnicity, deprivation and diagnosis year [21] . Univariable logrank tests were used to assess differences between survivor functions. Cox regression models included terms for sex, year of diagnosis, ethnicity and deprivation status. An overall model was used to compare the hazard ratios (HRs) between onset groups. Separate models for each onset group were used to assess all-cause and cause-specific mortality. Schoenfeld residuals and log-log plots of survival were used to assess the proportional hazards assumption.
Cox regression was not completed for non-diabetes-related deaths because of low numbers.
Results
Demographics of study cohort
The study cohort included 5498 individuals (with 100 959 person-years of follow-up); 4382 (79.7%) of whom had early-onset and 1116 (20.3%) of whom had late-onset Type 1 diabetes. The demographic data of the cohort are shown in Table 1 .
A greater number of people in the early-onset group were diagnosed with Type 1 diabetes in later years, with a third diagnosed after 1999 with ≤16 years' follow-up time. This contributed to similar median follow-up times per person for the late-onset group, despite data collection beginning 13 years earlier [median (range) follow-up 17.7 (1.5-38) years in the early-onset group vs 16.3 (0.3-25) years in the late-onset group].
All-cause mortality
There were 229 deaths, with the overall median (range) age at time of death being 29.7 (6.5-52.5) years. The median (range) age at death was 28.2 (6.5-48.9) years in the earlyonset group, and 33.1 (16.2-52.5) years in the late-onset group.
The overall SMR was 4.3 (95% CI 3.8 to 4.9). The SMRs in the early-and late-onset groups were similar [4.1 (95% CI 3.6 to 4.8) and 4.7 (95% CI 3.8 to 5.9); Fig. 1a] . Although most deaths occurred in males, the SMR (4.4 (95% CI 3.8 to 5.2); n = 165) for males was similar to that for females [4.0 (95% CI 3.2 to 5.2); n = 64 (Fig. 1b)] .
Ethnicity was known for 77.7% of all deaths (white, n = 169; South-Asian, n = 9). The SMR was significantly higher for white compared with South-Asian individuals [8.1 (95% CI 6.9 to 9.4) vs 3.4 (95% CI 1.7 to 6.4); Fig. 1c ].
There were no significant differences in SMRs between the most deprived [4.8 (95% CI 3.8 to 6.1)] and the least deprived deprivation category Cumulative mortality curves showed lower absolute mortality in the later diagnosis periods (Fig. 2) . The curve for period 3 begins to deviate from earlier periods 13 years after diabetes diagnosis for the early-onset group and 5 years after diabetes diagnosis for the late-onset group. Log-rank tests showed significant differences between the survivor functions of the three diagnosis periods in the early-onset but not in the late-onset group.
The late-onset group had double the risk of all-cause mortality compared with the early-onset group, when adjusted for sex, year of diagnosis, ethnicity and deprivation [HR 2.1 (95% CI 1.53 to 2.88)]. Female sex, diagnosis period 3 and South-Asian ethnicity all had significantly lower mortality risk compared with male sex, diagnosis period 1 and white ethnicity, respectively (Table 2 ). There were no significant differences found between deprivation groups.
The early-onset model found that female sex, diagnosis period 3 and South-Asian ethnicity were associated with significantly lower mortality rates. In the late-onset group, female sex and diagnosis period 3 had significantly lower mortality compared with male sex and diagnosis period 1 (Table 2) .
Diabetes-related mortality
After validation, 53 deaths (23.1%) were reclassified (Table S1 ). The majority were reclassified as Type 1 diabetes-related. Of the 229 death certificates, 123 mentioned diabetes; 48 specifically mentioned Type 1 diabetes.
There were 119 deaths with an underlying cause of Type 1 diabetes. The late-onset group had a significantly higher risk of death attributable to Type 1 diabetes than the early-onset group [HR 1.81 (95%CI 1.13 to 2.89)]. In the early-onset group, female sex and diagnosis period 3 had a significantly lower mortality risk attributable to Type 1 diabetes than male sex and diagnosis period 1. In the late-onset group, only deprivation was a significant factor, with the most deprived fifth having a significantly higher mortality risk compared with the least deprived fifth ( For deaths attributable to chronic complications, a significantly lower risk in the early-onset group was associated with female sex and diagnosis period 2. In the late-onset group, no significant associations with mortality were evident ( Table 2) .
Non-diabetes related mortality
Overall, the SMRs were significantly higher for respiratory failure [3.5 (95% CI 1.7 to 7.4)], mental disorder [4.9 (95% CI 2.6 to 9.1)] and suicide [2.5 (95% CI 1.5 to 4.3)].
Suicide was the only underlying cause of death where there was an excess in deaths for both the early-[SMR 2.1 (95% CI 1.0 to 4.2)] and the late-onset groups [SMR 3.5 (95% CI 1.6 to 7.7); Fig. 1a] . The SMRs for mental disorder-related deaths were significantly higher among both males [4.2 (95% CI 2.0 to 8.7) and girls/women [8.4 (95% CI 2.7 to 26.03)] in the study cohort compared with the general population. Males only had a significant excess mortality for suicide [SMR 2.8 (95% CI 1.6 to 4.8)] and respiratory failure [SMR 4.1 (95% CI 1.7 to 9.8) Fig. 1b] .
White ethnicity was associated with excess mental healthrelated mortality [12.9 (95% CI 6.7 to 24.8)] and with an excess of deaths attributable to accidents [2.8 (95% CI 1.8 to 4.1)]. South-Asian ethnicity was associated with an excess of deaths attributable to neoplasms [SMR 6.5 (95% CI 2.1 to 20.1) Fig. 1c] .
All deprivation status groups were found to be associated with an excess of deaths attributable to mental disorder. The two most deprived fifths had an excess of suicides (Fig. 1d) .
Discussion
The YRDCYP is the largest sub-national population-based cohort in which mortality in Type 1 diabetes in England has been examined. In the present study, we found that mortality risk in the Yorkshire population with Type 1 diabetes remains four to five times greater than in the general population of England and Wales. Although generalization of these results nationally should be undertaken with caution, the mortality burden is significant. No significant differences were found in all-cause SMRs according to age group, sex or deprivation status. A significantly higher SMR was associated with white than with South-Asian ethnicity, contradicting international studies in which minority ethnicities were associated with a higher mortality risk [2, 22, 23] . This result should, however, be considered in view of Onomap's limitations. Approximately 32% of the cohort had incomplete full names, so the South-Asian total could be underestimated. Additionally, no consideration was given to marital status name changes or identification of mixed ethnicities.
Classification errors may also have occurred for deprivation status. Larger populations live within the most deprived YRHA wards, leading to a higher proportion of the cohort classified as being in the most deprived fifth. The Index of Multiple Deprivation is calculated by 'Output Areas', which are approximately equal in population size, so provides a more equal spread across the five deprivation categories; however, the Townsend index was preferred because of its focus on material deprivation. No difference in trends were found in this study when using Index of Despite its limitations, this is the first UK study, to our knowledge, which has examined mortality by ethnicity and deprivation in a Type 1 diabetes population and highlights the importance of accurate recording and assignment of ethnicity and deprivation categories to examine future trends. The study showed that absolute all-cause mortality decreased significantly over time. Mortality risk in diagnosis period 3 was significantly lower for both the early-[HR 0.13 (95% CI 0.05 to 0.33)] and late-onset groups [HR 0.24 (95% CI 0.07 to 0.81)]. The follow-up time for period 3 was shorter for both onset groups compared with period 1, so future analysis with additional follow-up time will determine if this decrease in mortality continues. Despite improvements in all-cause mortality, no improvements were found in deaths from acute complications. This is concerning, particularly as the present study and other studies have shown that such deaths occur at younger ages [7, 10, 22, [24] [25] [26] . Additionally, Cox regression showed that only sex was significantly associated with mortality risk from acute complications, with a notable increased risk in boys/men. The 2015-2016 National Diabetes Audit and National Paediatric Diabetes Audit showed only a third of all individuals aged ≥12 years in England and Wales received all recommended annual care processes. Additionally, <20% reached the recommended HbA 1c , blood pressure and cholesterol targets. Improving specifically targeted diabetes care is essential in reducing premature deaths attributable to diabetes-related complications.
Reduced mortality risk for chronic complications was evident only in the early-onset group, as Harjutsalo et al. also found [3] ; however, the mortality risk associated with acute complications was significantly increased in their study in people with late-onset diabetes between 1970-1974 and 1985-1989 . The present study covers a more recent time period so can provide a contemporary representation of the population with Type 1 diabetes, including the introduction of intensive insulin treatment. Unfortunately, data on treatment regimen and other clinical variables (e.g. HbA 1c value and smoking status) were unavailable. This creates difficulty in ascertaining which variables contribute to mortality risk change.
Differences between the onset groups may be attributable to self-management education and experience, in combination with differences in the transition from paediatric to adult health services. There has been increased recognition of transitional issues, with the introduction of national clinical guidelines for England in 2016 [27] ; however, there is a lack of research on the specificity of such issues according to age of Type 1 diabetes onset and these are therefore not fully understood.
Sex differences were found in non-diabetes-related deaths. Excess deaths from respiratory failure and suicide were found in males only. The total number of deaths from respiratory failure among males was small (as was the case with other cause-specific SMRs for other demographic variables), so the SMR should be interpreted with caution.
Nearly 10% of all deaths among males were suicides. The difficulty in determining whether deaths as a result of acute complications were self-inflicted with the intention of suicide may mean that suicide rates are underestimated. Other studies have reported higher suicide rates in females [3, 26, 28] , although higher rates in males were found in the Diabetes Control and Complications Trial (DCCT) cohort. The DCCT also found nominally more suicides in the intensive treatment group compared with the conventional treatment group [29] . There is some evidence for increased mental health issues in Type 1 diabetes compared with the general population; however, the rate of increased mental health problems since the introduction of intensive insulin treatment has not been well examined.
We found a larger proportion of diabetes-related deaths in the present study compared with our previous study, partly as a result of the death classification [6] . Deaths originally classified as renal disease and ischaemic heart disease were re-classified as Type 1 diabetes. The ICD-10 code E10.2 was used for Type 1 diabetes with renal complications, but there is no ICD-10 code for Type 1 diabetes with ischaemic heart disease, so these were coded under E10.6 (Type 1 diabetes with specified complications). The accuracy of assigning ICD-10 codes without clinical verification is therefore questionable. This draws attention to possible underestimations in deaths attributable to Type 1 diabetes in previous studies. Only 54% of all death certificates mentioned diabetes and 21% specifically mentioned Type 1 diabetes. The absence of Type 1 diabetes recorded on death certificates for individuals with a confirmed diagnosis has been highlighted previously [30] .
In conclusion, there was excess mortality in the Yorkshire population with Type 1 diabetes compared with the general population of England and Wales. There is some evidence that all-cause mortality rates are falling, but the lack of improvement in diabetes-related deaths, especially those attributable to acute complications, is concerning. The re-classification of the underlying cause of deaths attributable to Type 1 diabetes suggests there has been an underestimation of deaths attributable to Type 1 diabetes in previous studies. Bold values indicate a statistically significant hazard ratio.
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